EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant immunotherapy in melanoma — from immune checkpoint discovery to a new treatment paradigm

Roger Olofsson Bagge, Piotr Rutkowski

Nowotwory. Journal of Oncology · 29.04.2026 · 76 (2) · 61-63

DOI: 10.5603/njo.110667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nowotwory. Journal of Oncology, online erschienen am 29.04.2026. Verfasst von Roger Olofsson Bagge und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bagge, R. O., & Rutkowski, P. (2026). Neoadjuvant immunotherapy in melanoma — from immune checkpoint discovery to a new treatment paradigm. Nowotwory. Journal of Oncology, 76(2), 61-63. https://doi.org/10.5603/njo.110667

Vancouver

Bagge RO, Rutkowski P. Neoadjuvant immunotherapy in melanoma — from immune checkpoint discovery to a new treatment paradigm. Nowotwory. Journal of Oncology. 2026;76(2):61-63. doi:10.5603/njo.110667

BibTeX
@article{Bagge2026,
  author = {Bagge, Roger Olofsson and Rutkowski, Piotr},
  title = {Neoadjuvant immunotherapy in melanoma — from immune checkpoint discovery to a new treatment paradigm},
  journal = {Nowotwory. Journal of Oncology},
  year = {2026},
  volume = {76},
  number = {2},
  pages = {61--63},
  doi = {10.5603/njo.110667}
}
Kostenlos starten →